Hematology & Oncology Doctors in Woodbury, NY Accepting Medicare

6 Hematology & Oncology doctors found. Showing 1 - 6

Lori Ann Attivissimo, M.D., F.A.C.P. Internal Medicine - Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 99 Sunnyside Blvd, Woodbury, NY 11797 Phone: 516-832-7100

Bruce Ira Kappel, MD Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 40 Crossways Park Dr, Ste 103, Woodbury, NY 11797 Phone: 516-921-5533    Fax: 516-364-4080

Joseph H Pipala, MD Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 40 Crossways Park Dr, Suite 103, Woodbury, NY 11797 Phone: 516-921-5533

Dr. Margarita Yarovikova, M.D. Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 40 Crossways Park Dr, Suite 103, Woodbury, NY 11797 Phone: 516-921-5533    Fax: 516-364-4080

Nancy Nan Szu Sun, MD Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 40 Crossways Park Drive, Woodbury, NY 11797 Phone: 516-921-5533    Fax: 516-364-4080

Laurence G Bilsky, MD Internal Medicine - Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 40 Crossways Park Drive, Suite 103, Woodbury, NY 11797 Phone: 516-921-5533    Fax: 516-364-4080

News Archive

Mercator signs license agreement with MD Anderson Cancer Center and closes $2.0 million seed round

Mercator Therapeutics, the first biopharmaceutical company to use in vivo phage display technology systematically to develop novel cancer drugs, today announced the signing of a license agreement with The University of Texas MD Anderson Cancer Center and the closing of a $2.0 million seed round.

Leicester study to focus on impact of food-based culture on children's life

They will examine the social and behavioural aspects of dining and their potential impact on school attendance and attitudes to learning.

Medovex successfully conducts live tissue test of DenerveX System

Medovex Corp., a developer of medical technology products, today announced that the company conducted a successful live tissue test of the DenerveX System under the most stringent standards required by FDA and other regulatory agencies.

Missing BAP1 gene renders immunotherapies ineffectual in uveal melanomas

New study from researchers in Finland and the United Kingdom reveals that tumors lacking a protein called BAP1 have an ineffective immune reaction against cancer, thus rendering immunotherapies ineffectual, particularly in uveal melanomas.

Study: Four risk factors estimated to reduce life expectancy in the U.S.

A study published this week in PLoS Medicine finds that four risk factors - smoking, high blood pressure, high blood sugar and obesity - explain a substantial amount of the disparity in life expectancy amongst the "Eight Americas", which are groups of the US population that can be defined by race, and location and socioeconomic features of counties they live in.

Read more Medical News

› Verified 5 days ago